Stay updated on Risankizumab Autoinjector Usability Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Autoinjector Usability Clinical Trial page.

Latest updates to the Risankizumab Autoinjector Usability Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved the government funding and operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedThe page layout and styling have been refreshed, while core study details such as eligibility criteria and locations remain unchanged.SummaryDifference0.4%

- Check71 days agoChange DetectedUpdated page with a new version (v3.2.0) and a government-operating-status notice; removed the previous version tag (v3.1.0).SummaryDifference3%

- Check78 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

- Check92 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Risankizumab Autoinjector Usability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Autoinjector Usability Clinical Trial page.